INDIGO Biosciences Stock

INDIGO Biosciences offers products and services on nuclear receptors, which comprise of therapeutic drug targets.

Sign up today and learn more about INDIGO Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About INDIGO Biosciences Stock

INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery process.

Funding History

December 2008$250K
September 2010$100K
October 2011$682K
August 2016$500K



Bob Culhane

Chief Scientific Officer

Jack Vanden Heuvel

President & CEO

Fred Marroni


Blake Peterson

Chief Technology Officer

Bruce Sherf


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: